In potassium oxonate-treated ApoE−/− mice, dioscin could ameliorate hyperuricemia-induced AS by regulating cholesterol metabolism via the farnesoid X receptor (FXR)-signaling pathway [110]. This evidence concerns the gene NR1H4 and hyperuricemia.